BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36253406)

  • 1. An intrinsic temporal order of c-JUN N-terminal phosphorylation regulates its activity by orchestrating co-factor recruitment.
    Waudby CA; Alvarez-Teijeiro S; Josue Ruiz E; Suppinger S; Pinotsis N; Brown PR; Behrens A; Christodoulou J; Mylona A
    Nat Commun; 2022 Oct; 13(1):6133. PubMed ID: 36253406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex.
    Aguilera C; Nakagawa K; Sancho R; Chakraborty A; Hendrich B; Behrens A
    Nature; 2011 Jan; 469(7329):231-5. PubMed ID: 21196933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.
    Nateri AS; Spencer-Dene B; Behrens A
    Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor.
    Dunn C; Wiltshire C; MacLaren A; Gillespie DA
    Cell Signal; 2002 Jul; 14(7):585-93. PubMed ID: 11955951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
    Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
    Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
    Ferrer I; Friguls B; Dalfó E; Planas AM
    Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
    Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
    Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain.
    Ortega-Pérez I; Cano E; Were F; Villar M; Vázquez J; Redondo JM
    J Biol Chem; 2005 May; 280(21):20867-78. PubMed ID: 15743762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
    Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
    Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase D complexes with C-Jun N-terminal kinase via activation loop phosphorylation and phosphorylates the C-Jun N-terminus.
    Hurd C; Waldron RT; Rozengurt E
    Oncogene; 2002 Mar; 21(14):2154-60. PubMed ID: 11948398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK).
    Todd JL; Rigas JD; Rafty LA; Denu JM
    Oncogene; 2002 Apr; 21(16):2573-83. PubMed ID: 11971192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat.
    Ferrer I; Blanco R; Carmona M
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):48-58. PubMed ID: 11597764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases.
    Minden A; Lin A; Smeal T; Dérijard B; Cobb M; Davis R; Karin M
    Mol Cell Biol; 1994 Oct; 14(10):6683-8. PubMed ID: 7935387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
    Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multisite phosphorylation of c-Jun at threonine 91/93/95 triggers the onset of c-Jun pro-apoptotic activity in cerebellar granule neurons.
    Reddy CE; Albanito L; De Marco P; Aiello D; Maggiolini M; Napoli A; Musti AM
    Cell Death Dis; 2013 Oct; 4(10):e852. PubMed ID: 24113186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protein kinase C inhibitor, Ro-31-7459, is a potent activator of ERK and JNK MAP kinases in HUVECs and yet inhibits cyclic AMP-stimulated SOCS-3 gene induction through inactivation of the transcription factor c-Jun.
    Wiejak J; Dunlop J; Stoyle C; Lappin G; McIlroy A; Pediani JD; Gao S; Yarwood SJ
    Cell Signal; 2012 Aug; 24(8):1690-9. PubMed ID: 22561846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase.
    Adler V; Pincus MR
    Ann Clin Lab Sci; 2004; 34(1):35-46. PubMed ID: 15038666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide.
    Ngoei KR; Catimel B; Church N; Lio DS; Dogovski C; Perugini MA; Watt PM; Cheng HC; Ng DC; Bogoyevitch MA
    Biochem J; 2011 Mar; 434(3):399-413. PubMed ID: 21162712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of Sec8 enhances the binding affinity of c-Jun N-terminal kinase (JNK)-interacting protein 4 for mitogen-activated protein kinase kinase 4 (MKK4) and suppresses the phosphorylation of MKK4, p38, and JNK, thereby inhibiting apoptosis.
    Tanaka T; Iino M; Goto K
    FEBS J; 2014 Dec; 281(23):5237-50. PubMed ID: 25244576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun.
    Humar M; Loop T; Schmidt R; Hoetzel A; Roesslein M; Andriopoulos N; Pahl HL; Geiger KK; Pannen BH
    Int J Biochem Cell Biol; 2007; 39(12):2278-88. PubMed ID: 17689131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.